SCHEMBL15313233

SCHEMBL15313233

CC/C(C)=C(/C)C(=O)Nc1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAPRT Q6XQN6 1/20 0.53
HSD17B10 Q99714 1/20 0.53
MAPT P10636 3/20 0.51
GAA P10253 1/20 0.51
SMN1; SMN2 Q16637 5/20 0.50
RAB9A P51151 5/20 0.50
NPC1 O15118 4/20 0.50
ALDH1A1 P00352 3/20 0.50
KMT2A Q03164 1/20 0.47
TAAR1 Q96RJ0 1/20 0.47
POLB P06746 1/20 0.47
TP53 P04637 2/20 0.47
EPHX1 P07099 1/20 0.47
TSHR P16473 1/20 0.47
EPHX2 P34913 1/20 0.47
CDK9 P50750 1/20 0.47
CLK4 Q9HAZ1 1/20 0.47
HDAC3 O15379 1/20 0.46
HDAC4 P56524 1/20 0.46
HDAC1 Q13547 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5329220 0.82 NAPRT (0.50) NAPRTHSD17B10MAPTGAASMN1; SMN2
SCHEMBL14379300 0.80 NAPRT (0.61) NAPRTHSD17B10MAPTGAASMN1; SMN2
SCHEMBL13324799 0.80 NAPRT (0.61) NAPRTHSD17B10MAPTGAASMN1; SMN2
SCHEMBL8526360 0.80 NAPRT (0.61) NAPRTHSD17B10MAPTGAASMN1; SMN2
SCHEMBL4073022 0.79 ALDH1A1 (0.54) NAPRTHSD17B10MAPTGAASMN1; SMN2
SCHEMBL2638458 0.79 NAPRT (0.59) NAPRTHSD17B10MAPTGAASMN1; SMN2
SCHEMBL6846903 0.79 MAPT (0.56) NAPRTHSD17B10MAPTGAASMN1; SMN2
SCHEMBL10420669 0.79 NAPRT (0.59) NAPRTHSD17B10MAPTGAASMN1; SMN2
SCHEMBL3815000 0.79 MAPT (0.56) NAPRTHSD17B10MAPTGAASMN1; SMN2
SCHEMBL3415038 0.76 NAPRT (0.67) NAPRTHSD17B10MAPTGAASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240189303-A1 METHODS AND COMPOSITIONS FOR PREVENTION AND TREATMENT OF CARDIAC HYPERTROPHY UNIVERSITY OF HAWAII 2024-06-13 US disclosed
US-20190192508-A1 METHODS AND COMPOSITIONS FOR PREVENTION AND TREATMENT OF CARDIAC HYPERTROPHY UNIV HAWAII (US) 2019-06-27 US disclosed
US-10137123-B2 Methods and compositions for prevention and treatment of cardiac hypertrophy UNIVERSITY OF HAWAII (US) 2018-11-27 US disclosed
US-20170231982-A1 METHODS AND COMPOSITIONS FOR PREVENTION AND TREATMENT OF CARDIAC HYPERTROPHY UNIVERSITY OF HAWAII 2017-08-17 US disclosed
US-20150352105-A1 METHODS AND COMPOSITIONS FOR PREVENTION AND TREATMENT OF CARDIAC HYPERTROPHY NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2015-12-10 US disclosed
US-9084786-B2 Methods and compositions for prevention and treatmentof cardiac hypertrophy UNIVERSITY OF HAWAII (US) 2015-07-21 US disclosed
US-20130274271-A1 METHODS AND COMPOSITIONS FOR PREVENTION AND TREATMENTOF CARDIAC HYPERTROPHY UNIVERSITY OF HAWAII (US) 2013-10-17 US disclosed